1. Home
  2. MURA vs SPRU Comparison

MURA vs SPRU Comparison

Compare MURA & SPRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MURA
  • SPRU
  • Stock Information
  • Founded
  • MURA 2013
  • SPRU 2008
  • Country
  • MURA Ireland
  • SPRU United States
  • Employees
  • MURA N/A
  • SPRU N/A
  • Industry
  • MURA
  • SPRU Auto Parts:O.E.M.
  • Sector
  • MURA
  • SPRU Consumer Discretionary
  • Exchange
  • MURA Nasdaq
  • SPRU Nasdaq
  • Market Cap
  • MURA 35.7M
  • SPRU 34.9M
  • IPO Year
  • MURA N/A
  • SPRU N/A
  • Fundamental
  • Price
  • MURA $2.08
  • SPRU $1.76
  • Analyst Decision
  • MURA Strong Buy
  • SPRU
  • Analyst Count
  • MURA 3
  • SPRU 0
  • Target Price
  • MURA $12.00
  • SPRU N/A
  • AVG Volume (30 Days)
  • MURA 465.5K
  • SPRU 105.2K
  • Earning Date
  • MURA 11-12-2025
  • SPRU 11-12-2025
  • Dividend Yield
  • MURA N/A
  • SPRU N/A
  • EPS Growth
  • MURA N/A
  • SPRU N/A
  • EPS
  • MURA N/A
  • SPRU N/A
  • Revenue
  • MURA N/A
  • SPRU $98,396,000.00
  • Revenue This Year
  • MURA N/A
  • SPRU $2.12
  • Revenue Next Year
  • MURA N/A
  • SPRU N/A
  • P/E Ratio
  • MURA N/A
  • SPRU N/A
  • Revenue Growth
  • MURA N/A
  • SPRU 23.43
  • 52 Week Low
  • MURA $0.95
  • SPRU $1.13
  • 52 Week High
  • MURA $4.74
  • SPRU $3.25
  • Technical
  • Relative Strength Index (RSI)
  • MURA 52.70
  • SPRU 65.52
  • Support Level
  • MURA $2.05
  • SPRU $1.47
  • Resistance Level
  • MURA $2.09
  • SPRU $1.71
  • Average True Range (ATR)
  • MURA 0.01
  • SPRU 0.09
  • MACD
  • MURA 0.01
  • SPRU 0.03
  • Stochastic Oscillator
  • MURA 66.67
  • SPRU 80.49

About MURA Mural Oncology plc

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.

About SPRU Spruce Power Holding Corporation

Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.

Share on Social Networks: